Adiponectin could inhibit NLRP3 inflammasome activation in nonalcoholic steatohepatitis or cerebral ischemia-reperfusion injury (41, 42). The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatohepatitis.